Nora Mohamed Abdelrazik

This small, early-stage study is testing if an oral medication called roflumilast can help control moderate-to-severe eczema (atopic dermatitis). For 12 weeks, 36 participants aged 12 and older will take the pill daily. Researchers will measure changes in skin rash, itch, and sle…